Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	Oliena Studio Stroke and language recovery: 9000+ videos Español • Italiano • Sardu • English | PDF+

Hyperlipoproteinemias

Free Subscription Articles published in Can J Cardiol Retrieve available abstracts of 19 articles: HTML format Text format

Single Articles

June 2019
1. BERARD E, Bongard V, Haas B, Dallongeville J, et al
   Prevalence and Treatment of Familial Hypercholesterolemia in France.
   Can J Cardiol. 2019;35:744-752.
   PubMed     Text format     Abstract available
   
   
   
2. FRANCIS GA, Brunham LR
   Low Rates of Identification and Treatment of Familial Hypercholesterolemia in France and Elsewhere: A Call for Universal Screening.
   Can J Cardiol. 2019;35:699-700.
   PubMed     Text format    
   
   
   December 2018
3. BRUNHAM LR, Ruel I, Aljenedil S, Riviere JB, et al
   Canadian Cardiovascular Society Position Statement on Familial Hypercholesterolemia: Update 2018.
   Can J Cardiol. 2018;34:1553-1563.
   PubMed     Text format     Abstract available
   
   
   October 2018
4. IACOCCA MA, Wang J, Sarkar S, Dron JS, et al
   Whole-Gene Duplication of PCSK9 as a Novel Genetic Mechanism for Severe Familial Hypercholesterolemia.
   Can J Cardiol. 2018;34:1316-1324.
   PubMed     Text format     Abstract available
   
   
   
5. PAQUETTE M, Baass A
   A Novel Cause of Familial Hypercholesterolemia: PCSK9 Gene Duplication.
   Can J Cardiol. 2018;34:1259-1260.
   PubMed     Text format    
   
   
   August 2018
6. BAASS A, Hegele RA
   Getting Real With PCSK9 Inhibitors in Familial Hypercholesterolemia.
   Can J Cardiol. 2018;34:959-961.
   PubMed     Text format    
   
   
   
7. RAZEK O, Cermakova L, Armani H, Lee T, et al
   Attainment of Recommended Lipid Targets in Patients With Familial Hypercholesterolemia: Real-World Experience With PCSK9 Inhibitors.
   Can J Cardiol. 2018;34:1004-1009.
   PubMed     Text format     Abstract available
   
   
   July 2018
8. MCPHERSON R
   The Cardiovascular Burden of Undiagnosed Familial Hypercholesterolemia: Need to Modify Guidelines to Encourage Earlier Diagnosis and Therapy.
   Can J Cardiol. 2018 Jul 11. pii: S0828-282X(18)30503.
   PubMed     Text format    
   
   
   May 2018
9. RUEL I, Brisson D, Aljenedil S, Awan Z, et al
   Simplified Canadian Definition for Familial Hypercholesterolemia.
   Can J Cardiol. 2018 May 19. pii: S0828-282X(18)30383.
   PubMed     Text format     Abstract available
   
   
   
10. MANCINI GBJ, Hegele RA
    Can We Eliminate Low-Density Lipoprotein Cholesterol-Related Cardiovascular Events Through More Aggressive Primary Prevention Therapy?
    Can J Cardiol. 2018;34:546-551.
    PubMed     Text format     Abstract available
    
    
    October 2017
11. PAQUETTE M, Dufour R, Baass A
    Scavenger Receptor LOX1 Genotype Predicts Coronary Artery Disease in Patients With Familial Hypercholesterolemia.
    Can J Cardiol. 2017;33:1312-1318.
    PubMed     Text format     Abstract available
    
    
    May 2017
12. AL KINDI M, Belanger AM, Sayegh K, Senouci S, et al
    Aortic Calcification Progression in Heterozygote Familial Hypercholesterolemia.
    Can J Cardiol. 2017;33:658-665.
    PubMed     Text format     Abstract available
    
    
    
13. RAJAMANNAN NM, Nattel S
    Aortic Vascular Calcification: Cholesterol Lowering Does Not Reduce Progression in Patients With Familial Hypercholesterolemia-or Does It?
    Can J Cardiol. 2017;33:594-596.
    PubMed     Text format    
    
    
    
14. NAUGLER C, Cook C, Morrin L, Wesenberg J, et al
    Statin Prescriptions for High-Risk Patients Are Increased by Laboratory-Initiated Framingham Risk Scores: A Quality-Improvement Initiative.
    Can J Cardiol. 2017;33:682-684.
    PubMed     Text format     Abstract available
    
    
    
15. BRENNAN ET, Joy TR
    Management Strategies for Statin-Associated Muscle Symptoms: How Useful Is Same-Statin Rechallenge?
    Can J Cardiol. 2017;33:666-673.
    PubMed     Text format     Abstract available
    
    
    March 2017
16. FILLER G, Lee M, Hegele RA
    Barriers to the Implementation of Lipoprotein Apheresis in Canada.
    Can J Cardiol. 2017;33:409-411.
    PubMed     Text format     Abstract available
    
    
    
17. WATERS DD, Boekholdt SM
    An Evidence-Based Guide to Cholesterol-Lowering Guidelines.
    Can J Cardiol. 2017;33:343-349.
    PubMed     Text format     Abstract available
    
    
    November 2016
18. GENEST J
    Familial Hypercholesterolemia: Awareness, Appraisal, and Action.
    Can J Cardiol. 2016 Nov 14. pii: S0828-282X(16)31014.
    PubMed     Text format    
    
    
    September 2016
19. BRUNHAM LR, Cermakova L, Lee T, Priecelova I, et al
    Contemporary Trends in the Management and Outcomes of Patients With Familial Hypercholesterolemia in Canada: A Prospective Observational Study.
    Can J Cardiol. 2016 Sep 3. pii: S0828-282X(16)30892.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Hyperlipoproteinemias is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: